TLR9 agonist acts by different mechanisms synergizing with bevacizumab in sensitive and cetuximab-resistant colon cancer xenografts

Synthetic agonists of Toll-like receptor 9 (TLR9), a class of agents that induce specific immune response, exhibit antitumor activity and are currently being investigated in cancer patients. Intriguingly, their mechanisms of action on tumor growth and angiogenesis are still incompletely understood....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Damiano, Vincenzo, Caputo, Rosa, Garofalo, Sonia, Bianco, Roberto, Rosa, Roberta, Merola, Gerardina, Gelardi, Teresa, Racioppi, Luigi, Fontanini, Gabriella, De Placido, Sabino, Kandimalla, Ekambar R., Agrawal, Sudhir, Ciardiello, Fortunato, Tortora, Giampaolo
Formato: Artigo
Idioma:Inglês
Publicado em: National Academy of Sciences 2007
Assuntos:
Biological Sciences
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1920540/
https://ncbi.nlm.nih.gov/pubmed/17636117
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0705226104
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados